Publications by authors named "Bruno Massidda"

Claim this Profile
A
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Bruno Massidda

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Bruno Massidda

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for 6 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.
Vincenzo Formica, Maria Teresa Ionta, Bruno Massidda, Giacomo Vessia, Luigi Maiorino

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Annamaria Ruzzo, Francesco Graziano, Fabio Galli, Elisa Giacomini, Irene Floriani, Bruno Massidda

Sci Rep· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy.
Grazia Palomba, Francesco Atzori, Mario Budroni, MariaNeve Ombra, Antonio Cossu, Bruno Massidda

J Transl Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
Antonio Daponte, Simona Signoriello, Luigi Maiorino, Bruno Massidda, Ester Simeone

J Transl Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
Grazia Palomba, Maria Colombino, Antonio Contu, Bruno Massidda, Giovanni Baldino

J Transl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitude of Italian medical oncologists toward palliative care for patients with advanced cancer: results of the SIO project.
Sandro Barni, Marco Maltoni, Guido Tuveri, Paolo Pronzato, Enrico Cortesi, Bruno Massidda

Support Care Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Pasquale Comella, Bruno Massidda, Donato Natale, Carlo Putzu, Claudia Sandomenico

Clin Colorectal Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.
Bruno Massidda, Mariacristina Sini, Mario Budroni, Francesco Atzori, Mariacristina Deidda

BMC Cancer· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory breast cancer in Italy: epidemiological and clinical aspects.
Maria Teresa Ionta, Francesco Atzori, Bruno Massidda

Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, Vittorio Gebbia, Giacomo Cartenì, Bruno Massidda

J Clin Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients.
Maria Teresa Ionta, Maria Teresa Perra, Francesco Atzori, Cristina Maxia, Valeria Pusceddu, Bruno Massidda

Exp Ther Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting insulin-like growth factor type 1 receptor in cancer therapy.
Francesco Atzori, Tiffany A Traina, Maria Teresa Ionta, Bruno Massidda

Target Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (
Maria Teresa Ionta, Francesco Atzori, Maria Cristina Deidda, Valeria Pusceddu, Sergio Palmeri, Bruno Massidda

Oncologist· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.
Pasquale Comella, Vito Lorusso, Luigi Maiorino, Rossana Casaretti, Michele Cannone, Bruno Massidda

Cancer Chemother Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, Antonio Farris, Donato Natale

J Cancer Res Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer.
Valeria Pusceddu, Barbara Frau, Daniela Guerzoni, Gualtiero Catani, Monica Murgia, Bruno Massidda

Breast J· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Francesco Di Costanzo, Silvia Gasperoni, Luigi Manzione, Giancarlo Bisagni, Roberto Labianca, Bruno Massidda

J Natl Cancer Inst· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
Bruno Massidda, Francesco Atzori, Antioco Scanu, Antonio Contu, Antonio Farris

Oncology· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Maria Di Bartolomeo, Roberto Buzzoni, Luigi Mariani, Erminia Ferrario, Dotti Katia, Bruno Massidda

Oncology· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
Pasquale Comella, Carlo Putzu, Bruno Massidda, Giovanni Condemi, Giuseppe De Cataldis

Lung Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
Sergio Palmeri, Vito Lorusso, Laura Palmeri, Marina Vaglica, Camillo Porta, Bruno Massidda

Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.
Pasquale Comella, Bruno Massidda, Sergio Palmeri, Carlo Putzu, Vincenzo De Rosa

Anticancer Drugs· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
Sandro Pignata, Sabino De Placido, Rosalbino Biamonte, Giovanni Scambia, Giovanni Di Vagno, Bruno Massidda

BMC Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis